332 related articles for article (PubMed ID: 11301351)
21. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2001 Nov; 32(11):1225-31. PubMed ID: 11727262
[TBL] [Abstract][Full Text] [Related]
22. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis.
Bovée JV; Cleton-Jansen AM; Rosenberg C; Taminiau AH; Cornelisse CJ; Hogendoorn PC
J Pathol; 1999 Dec; 189(4):454-62. PubMed ID: 10629543
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.
Chen S; Fritchie K; Wei S; Ali N; Curless K; Shen T; Brini AT; Latif F; Sumathi V; Siegal GP; Cheng L
Hum Pathol; 2017 Jul; 65():239-246. PubMed ID: 28552826
[TBL] [Abstract][Full Text] [Related]
24. Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?
Knösel T; Werner M; Jung A; Kirchner T; Dürr HR
Pathol Res Pract; 2014 Mar; 210(3):194-7. PubMed ID: 24405942
[TBL] [Abstract][Full Text] [Related]
25. Amplification of the c-myc proto-oncogene in human chondrosarcoma.
Castresana JS; Barrios C; Gómez L; Kreicbergs A
Diagn Mol Pathol; 1992 Dec; 1(4):235-8. PubMed ID: 1342971
[TBL] [Abstract][Full Text] [Related]
26. Grade 2 chondrosarcoma: stage I or stage II tumor?
Reith JD; Horodyski MB; Scarborough MT
Clin Orthop Relat Res; 2003 Oct; (415):45-51. PubMed ID: 14612628
[TBL] [Abstract][Full Text] [Related]
27. Lack of Bcl10 mutations in malignant cartilaginous tumors.
Park YK; Park HR; Kim YW; Chi SG; Unni KK
Int J Mol Med; 2002 Mar; 9(3):217-9. PubMed ID: 11836626
[TBL] [Abstract][Full Text] [Related]
28. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
Anract P; Tomeno B; Forest M
Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
[TBL] [Abstract][Full Text] [Related]
29. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of p53 protein and point mutation of K-ras genes in primary carcinoma of the small intestine.
Nishiyama K; Yao T; Yonemasu H; Yamaguchi K; Tanaka M; Tsuneyoshi M
Oncol Rep; 2002; 9(2):293-300. PubMed ID: 11836595
[TBL] [Abstract][Full Text] [Related]
31. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
Kraus MC; Seelig MH; Linnemann U; Berger MR
Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
[TBL] [Abstract][Full Text] [Related]
32. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
33. Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma.
Röpke M; Boltze C; Neumann HW; Roessner A; Schneider-Stock R
Pathol Res Pract; 2003; 199(6):437-44. PubMed ID: 12924447
[TBL] [Abstract][Full Text] [Related]
34. Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas.
Dornauer K; Söder S; Inwards CY; Bovee JV; Aigner T
Pathol Int; 2010 May; 60(5):365-72. PubMed ID: 20518886
[TBL] [Abstract][Full Text] [Related]
35. Synchronous multifocal bone sarcomas--a case report and molecular pathologic investigation.
Walter H; Schneider-Stock R; Mellin W; Günther T; Nebelung W; Roessner A
Gen Diagn Pathol; 1995 May; 141(1):67-74. PubMed ID: 8542510
[TBL] [Abstract][Full Text] [Related]
36. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
37. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
38. [Frequency of K-ras mutation in biliary and pancreatic tumors].
Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
[TBL] [Abstract][Full Text] [Related]
39. Dedifferentiated chondrosarcomas arising in preexisting osteochondromas.
Staals EL; Bacchini P; Mercuri M; Bertoni F
J Bone Joint Surg Am; 2007 May; 89(5):987-93. PubMed ID: 17473135
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma.
Bovée JV; Cleton-Jansen AM; Kuipers-Dijkshoorn NJ; van den Broek LJ; Taminiau AH; Cornelisse CJ; Hogendoorn PC
Genes Chromosomes Cancer; 1999 Nov; 26(3):237-46. PubMed ID: 10502322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]